Ningbo David Medical Device Co., Ltd. (SHE:300314)
China flag China · Delayed Price · Currency is CNY
11.53
-0.07 (-0.60%)
Sep 4, 2026, 3:04 PM CST

SHE:300314 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
579.27578.62516.93606.83496.58469.87
Other Revenue
5.415.4110.111.479.464.26
584.68584.03527.03618.3506.04474.13
Revenue Growth
14.09%10.82%-14.76%22.18%6.73%3.18%
Cost of Revenue
293.65273.01233.47263.61210.28185.25
Gross Profit
291.03311.02293.55354.68295.76288.88
Selling, General & Admin
169.93174.81172.44172.15155.19166.5
Research & Development
56.559.355.4648.0645.8749.69
Other Operating Expenses
5.634.565.036.727.986.81
Operating Expenses
232.54239.96233.16227.43210.26223.27
Operating Income
58.4871.0660.39127.2585.565.61
Interest Expense
--0.43-0.47-0.6-0.35-0.03
Interest & Investment Income
19.2425.8410.7125.875.3918.9
Currency Exchange Gain (Loss)
-5.72-5.720.836.3317.05-2.86
Other Non Operating Income (Expenses)
-15.07-0.48-0.46-0.3-0.27-0.23
EBT Excluding Unusual Items
56.9390.2771.01158.55107.3181.38
Impairment of Goodwill
---0.52-1.53--
Gain (Loss) on Sale of Investments
5.961.78-10.060.26-4.880.69
Gain (Loss) on Sale of Assets
-0.27-0.39-0.01-0.230.020.12
Asset Writedown
-1.47-0.02-0.01-0.08-0.02-0.04
Other Unusual Items
5.937.022.989.249.495.05
Pretax Income
67.0898.6663.38166.22111.9287.19
Income Tax Expense
6.9211.66.1218.6114.566.99
Net Income
60.1687.0557.26147.6197.3680.21
Net Income to Common
60.1687.0557.26147.6197.3680.21
Net Income Growth
-2.51%52.02%-61.21%51.62%21.39%-41.11%
Shares Outstanding (Basic)
290290286289286286
Shares Outstanding (Diluted)
290290286289286286
Shares Change
1.39%1.35%-1.08%1.08%-0.04%-1.14%
EPS (Basic)
0.210.300.200.510.340.28
EPS (Diluted)
0.210.300.200.510.340.28
EPS Growth
-3.84%50.00%-60.78%50.00%21.43%-40.43%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
53.9234.22-45.8294.8161.7944.95
Free Cash Flow Per Share
0.190.12-0.160.330.220.16
Dividend Per Share
0.0800.0800.0870.1800.1500.100
Dividend Growth
-8.05%-8.05%-51.67%20.00%50.00%-33.33%
Gross Margin
49.78%53.25%55.70%57.36%58.45%60.93%
Operating Margin
10.00%12.17%11.46%20.58%16.89%13.84%
Profit Margin
10.29%14.91%10.87%23.87%19.24%16.92%
Free Cash Flow Margin
9.22%5.86%-8.70%15.33%12.21%9.48%
EBITDA
80.3292.4884.68154.57108.9389.76
EBITDA Margin
13.74%15.83%16.07%25.00%21.53%18.93%
D&A For EBITDA
21.8421.4124.2927.3223.4324.15
EBIT
58.4871.0660.39127.2585.565.61
EBIT Margin
10.00%12.17%11.46%20.58%16.89%13.84%
Effective Tax Rate
10.31%11.76%9.65%11.20%13.01%8.01%
Revenue as Reported
332.77584.03527.03618.3506.04474.13
Advertising Expenses
-9.383.224.513.324.06